ŌURA, the maker of the Oura Ring and a global leader in preventive health technology, announced that it has raised over $900 million in new funding to expand its platform, accelerate product innovation, and strengthen its global presence. The round was led by Fidelity Management & Research Company, with significant participation from ICONIQ, Whale Rock, and Atreides, valuing the company at approximately $11 billion. The new financing will support ŌURA’s mission to make proactive, data-driven health accessible to millions of people worldwide.
Since its founding in Finland in 2013, ŌURA has transformed the wearables industry by pioneering personalized health insights through its flagship product, the Oura Ring. The company has sold over 5.5 million rings, with more than half of those sales occurring in the past year alone.
This surge in adoption has been accompanied by record financial performance: ŌURA reported over $500 million in revenue for 2024, doubling its previous year’s performance, and is on track to surpass $1 billion in annual revenue in 2025 while maintaining profitability.
The new investment will fund further development of AI-driven health features, expansion into new global markets, and the rollout of innovations across women’s health, cardiovascular monitoring, and stress management.
ŌURA’s technology delivers real-time metrics such as sleep quality, readiness, activity tracking, heart rate variability, and temperature monitoring. These insights empower users to make informed decisions about their wellbeing while supporting employers, insurers, and healthcare providers in advancing preventive care at scale.
As part of its ongoing evolution, ŌURA announced a leadership change within its board of directors. David Shuman, founder of Lateralus Holdings and a board member since 2016, has been appointed Chair of the Board, succeeding Eurie Kim, who has held the role since 2019.
Kim will remain an active board member and continue advising the company as it enters its next phase of growth. ŌURA also plans to expand its board with the nomination of Wen Hsieh, founding managing partner at Matter Venture Partners and former managing partner at Kleiner Perkins, bringing deep expertise in hardware, semiconductor design, and energy technology.
Recent product launches demonstrate ŌURA’s expanding ecosystem as a health platform rather than a single device. The Oura Ring 4 Ceramic, introduced in new color variants, showcases the company’s design innovation, while the Oura Ring 4 Charging Case enhances user experience. Additionally, the new Health Panels feature allows members to schedule and view lab test results directly within the Oura App, bridging the gap between daily wellness tracking and clinical health data.
With its strong financial position, expanding ecosystem, and rapidly growing member base, ŌURA is now one of the most valuable standalone wearable companies in the world. Its next phase of growth will focus on using AI and longitudinal health data to predict and prevent disease, aligning with its mission to move healthcare from reactive treatment to proactive prevention.
KEY QUOTES:
“This new funding is a testament to the strength of ŌURA’s business and the trust millions of members place in us every day. We’re proud to be building not just a product, but a global movement toward proactive health—helping people understand their bodies, make better lifestyle decisions, and connect more effectively with their healthcare providers. With this investment, we will accelerate innovation, expand our global reach, and set a new standard for what wearables can achieve in advancing preventive health.”
“Eurie and David have been instrumental in OURA’s success. Since joining the board in 2019, Eurie has been a trusted partner as we’ve rapidly grown our consumer awareness. I look forward to her continued guidance on the board through the company’s next phase of growth. Oura has benefited greatly from David’s leadership and good judgement across long-term strategy, fundraising, recruiting, partnerships, and corporate development—and I know he’ll be instrumental in our continued success and growth as we enter our next chapter.”
Tom Hale, CEO of ŌURA
“David has been a wonderful board partner to me during my tenure as chair, and I look forward to continuing to collaborate with him as we help ŌURA reach its potential.”
Eurie Kim, Former Chair of the Board
“ŌURA’s growth and impact over the past year have been truly remarkable. The company has doubled revenue, expanded its global reach, and delivered transformative solutions that are reshaping the wearables industry. I’m also thrilled for Wen’s upcoming nomination to the board—he brings a wealth of knowledge that will support ŌURA’s mission to make health a daily practice.”
David Shuman, Chair of the Board, ŌURA
